NCT03178006 is a clinical trial in Microbial Colonization, sponsored by Rio de Janeiro State University.

Who is sponsoring NCT03178006?

NCT03178006 is sponsored by Rio de Janeiro State University.

What condition does NCT03178006 study?

NCT03178006 studies Microbial Colonization.

Is NCT03178006 still recruiting?

NCT03178006 is currently completed. Last updated 2 July 2025.

Last reviewed 2025-07-02 · How we verify

NCT03178006

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between Intestinal Microbiota, Inflamatory Biomarkers, Intestinal Morphology, Hepatic Fibrosis Degree and Vascular Reactivity.

Completed Last updated 2 July 2025

What this trial tests

trial in Microbial Colonization in 46 participants. Completed in 4 November 2016.

Timeline

5 January 2015

Primary endpoint
4 November 2016

4 November 2016

Quick facts

Lead sponsor	Rio de Janeiro State University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	46
Start date	5 January 2015
Primary completion	4 November 2016
Estimated completion	4 November 2016

Conditions studied

Microbial Colonization — all drugs for Microbial Colonization →

Sponsor

Rio de Janeiro State University

Who can join

Adults 18 to 50, any sex, with Microbial Colonization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Metabolic, inflammatory status, intestinal permeability biomarkers, and gut microbiota composition were investigated in individuals with varying levels of adiposity and glucose tolerance. This project focuses on exploring the associations between gut permeability and metabolic profiles.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Ghrelin and glucagon-like peptide-1 according to body adiposity and glucose homeostasis.
Lopes KG, da Silva VL, de Azevedo Marques Lopes F, Bouskela E, et al · · 2023 · cited 1× · PMID 37252699 · DOI 10.20945/2359-3997000000611
Gut Microbiota, Intestinal Barrier Function, and Metabolism Across Adiposity and Glucose Tolerance.
Lopes KG, de Souza MDGC, Marques Lopes FA, da Silva Júnior VL, et al · · 2025 · PMID 41228453 · DOI 10.3390/nu17213380

Verify or expand the search:

Other recruiting trials for Microbial Colonization

Currently open trials in the same condition.

NCT06970262 — FMT for Lung and Associated-organ Rescue Efficacy in ARDS Patients · NA · recruiting
NCT06805994 — Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment · Phase 1 · recruiting
NCT06938386 — Pilot Haskap Metabolite Timing Project · NA · active not recruiting
NCT06920641 — Effects of Tagatose on Glycemic Response and Gastrointestinal Microbiota in Healthy Adults · NA · recruiting
NCT06541808 — Balance, Autonomic Response, and Sensory Modulation to Dosage of Mechanical Vagal Stimulation in Healthy Adults · NA · recruiting

Other Rio de Janeiro State University trials

Trials by the same sponsor.

NCT06799598 — DUOSTIM and AI: is There a Difference Between Oocyte Performance in the Follicular and Luteal Phases? · completed
NCT05931939 — Laparoscopic Ileal Interposition and Weight Regain · NA · recruiting
NCT04193397 — Effects of Physical Training on Health Markers of Post-bariatric Patients · NA · completed
NCT05950698 — Obesity and Bariatric Surgery According to a Biopsychosocial Perspective. · recruiting
NCT05728320 — Glycemic Patterns After Bariatric Surgery and High Glycemic Variability and Hypoglycemia Unawareness Risk Factors · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03178006 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rio de Janeiro State University
Last refreshed: 2 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03178006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing